Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. CytoDyn Inc (CYDY) Message Board

Ya, that article was crap. I responded to their

Message Board Public Reply | Private Reply | Keep | Replies (1)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 155513
(Total Views: 467)
Posted On: 10/25/2019 11:29:10 AM
Avatar
Posted By: LongPennyPincher
Re: Evil Rabbit #9960
Ya, that article was crap. I responded to their article with this.. But noticed approvals are on, so most likely will not be approved.

"Think about this...

Here are the FACTS:
FDA is requiring safety data from the last group of 700mg patients.
FDA already knows efficacy is at 92% and rising on 700mg
FDA already knows efficacy is at 95% with 525mg
FDA already knows efficacy is around 70% on 350mg
FDA already knows Leronlimab / Pro140 has NO SAE's - THIS IS HUGE seeing as though there are open lawsuits against GILD for side effects related to NASH!
NP in one of his statements says, "You will understand the reason for delay soon."

Now lets ask ourselves....

If FDA already has safety data for 525mg and knows it is 95% why are they requiring 700mg safety data? Especially when efficacy of competing drugs are only in the 40% range...

My opinion on this,

Occupancy Test and Combo Therapy will be approved almost instantly with these results, mono will be approved right after the 2nd Phase 3 trial is complete or possibly even sooner with all 3 doses approved with occupancy testing required.

If cancer results are positive like in animal studies, with over 98% metastasis reduced and tumor shrinkage 40% to 60% - This could be approved for use in less than a couple months with off-label use for HIV mono and all the indications that "YOU" state are like "tilting at windmills".

With Samsung heading the manufacturing of this drug, the science behind it, the no side effects portion, the proven efficacy in over 800 patients, no resistances to the drug in over 5 years, multiple indications on Cancer, NASH, GvHD, MS, Hashimotos, Lupus, Diabetes, HIV, Stroke, arthritis, and many others, only a fool, or a person with ulterior motives would write an article like this. When they get to BLA the NBA with another company kicks in and they will have 90 million to play with +50% royalties on licensing agreements. There is also something in the works for "possible" binding licensing agreement for U.S only by EOM. Shorting this is like playing with dynamite with a short fuse at this point of the game.

Maybe you should take a little time off of trying to manipulate the stock, and actually read up on CCR5 and its many affects on the human body.

And if we are quoting articles, lets just say "13 shots on goal" was definitely a better read."



(2)
(0)




CytoDyn Inc (CYDY) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us